About Jindal Drugs Private Limited
Data last updated: 23 December 2025
Jindal Drugs Private Limited is a private limited company based in Mumbai, Maharashtra, India. It specialises in specialty chemicals, a part of the broader chemicals and materials sector. Incorporated on 04 November 1982, the company has been in operation for over 44 years.
Registered with ROC Mumbai under CIN U24114MH1982PTC028621.
Capital: an authorised share capital of ₹27.26 Cr and a paid-up capital of ₹11.96 Cr. Formerly known as Jindal Dye Intermediate Limited and Jindal Dye Intermediate Private Limited. It is led by directors including Mamta Ajay Jindal and Ishaan Jindal.
Last AGM: 30 September 2025. Financial statements filed for year ended 31 March 2025. Office: 12A Bakhtawar 12Th Floor 229 Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹418.88 Cr, a growth of 26% compared to the previous year.
The company has a workforce of approximately 47 employees as per the latest available data. Its group structure includes 1 subsidiary.
The company is associated with 1 brand - Jindal Drugs. As per MCA filings, the company has open charges of ₹696 Cr and satisfied charges of ₹797.98 Cr on record.
The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website jindaldrugs.com.
-
EmailLocked
-
TelephoneLocked
-
Website
-
Social Media
-
Registered Address12A Bakhtawar 12Th Floor 229 Nariman Point, Mumbai, Maharashtra, India – 400021
-
IndustryChemicals and Materials, Specialty Chemicals
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Name History of Jindal Drugs Private Limited
Jindal Drugs Private Limited has undergone 3 name changes throughout its history. The company was previously known as Jindal Dye Intermediate Limited, Jindal Dye Intermediate Private Limited, and Jindal Drugs Limited. The current legal name is Jindal Drugs Private Limited, reflecting the company's evolution and rebranding over time.
| Company Name | Status |
|---|---|
| Jindal Drugs Private Limited | Current |
| Jindal Dye Intermediate Limited | Previous |
| Jindal Dye Intermediate Private Limited | Previous |
| Jindal Drugs Limited | Previous |
CIN History of Jindal Drugs Private Limited
Jindal Drugs Private Limited has one previous CIN (Corporate Identification Number): U24114MH1982PLC028621. The current CIN is U24114MH1982PTC028621, which is the unique identifier assigned by the Registrar of Companies.
| CIN | Status |
|---|---|
| U24114MH1982PTC028621 | Current |
| U24114MH1982PLC028621 | Previous |
Associated Brands with Jindal Drugs Private Limited
Jindal Drugs Private Limited operates one associated brand: Jindal Drugs. These brands represent Jindal Drugs Private Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Manufacturing and exporting of essential oils and derivatives in India. | jindaldrugs.com |
Business Activity of Jindal Drugs Private Limited
Jindal Drugs Private Limited is engaged in the principal business activity of manufacturing, with detailed activities including other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| C | Manufacturing | C13 | Other manufacturing including jewellery, musical instruments, medical instruments, sports goods, etc. activities | Locked |
Business activity turnover details for Jindal Drugs Private Limited
Turnover contribution percentages and historical activity changes require an active report plan.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Auditor Details of Jindal Drugs Private Limited
Jindal Drugs Private Limited is audited by MSKA & Associates for the financial year 2021. The auditor plays a crucial role in ensuring financial transparency and compliance with accounting standards.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MSKA & Associates | Locked | Locked | Locked |
Complete auditor history for Jindal Drugs Private Limited
Appointment status, appointment dates, cessation dates, and historical auditor changes require an active report plan.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Board of Directors of Jindal Drugs Private Limited
Jindal Drugs Private Limited is currently managed by 6 directors, with 8 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
Financials of Jindal Drugs Private Limited FY 2025 filings available
Jindal Drugs Private Limited reported revenue of ₹418.88 Cr (up 26.00% YoY) for FY 2025.
Ten-year financial statements for Jindal Drugs Private Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Jindal Drugs Private Limited
Shareholding and ownership data for Jindal Drugs Private Limited
Promoter, institutional, public, and beneficial ownership values require an active report plan.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Group Structure of Jindal Drugs Private Limited
Jindal Drugs Private Limited has 1 subsidiary company. This group structure data is as of FY 2023. The corporate group structure reflects Jindal Drugs Private Limited's business expansion strategy and organizational complexity.
| Company Name | CIN | Shares Held |
|---|---|---|
| Jindal Multitrade Private Limited | U65923MH2013PTC251430 | Locked |
Showing major subsidiaries. Total: 1.
Charges & Borrowings of Jindal Drugs Private Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 09 May 2025 | Others | ₹30 Cr | Open |
| 31 Oct 2022 | Others | ₹50 Cr | Open |
| 25 Mar 2014 | Sbicap Trustee Company Limited | ₹600 Cr | Open |
| 19 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8 Cr | Open |
| 14 Jul 1998 | Oversea- Chinese Banking Corp Ltd | ₹8 Cr | Open |
Total charge records: 38 View all charges
Employees and EPFO Compliance at Jindal Drugs Private Limited
Jindal Drugs Private Limited has a workforce of 47 employees as of Mar 31, 2024.
Employee and EPFO history for Jindal Drugs Private Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of Jindal Drugs Private Limited
GST registrations and filing compliance for Jindal Drugs Private Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for Jindal Drugs Private Limited
Credit ratings, litigation, and regulatory alerts for Jindal Drugs Private Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Jindal Drugs Private Limited
MSME payment history for Jindal Drugs Private Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Jindal Drugs Private Limited
Corporate group structure for Jindal Drugs Private Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Jindal Drugs Private Limited
MCA filings and documents for Jindal Drugs Private Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on Jindal Drugs Private Limited
Frequently Asked Questions about Jindal Drugs Private Limited
Jindal Drugs Private Limited is an active private limited company in the chemicals and materials sector based in Mumbai, Maharashtra, India. It was incorporated on 04 November 1982 (44+ years old) and is registered under CIN U24114MH1982PTC028621. The company has 47 employees.
Jindal Drugs Private Limited reported revenue of ₹418.88 Cr for FY 2025 (up 26.00% YoY).
The current directors of Jindal Drugs Private Limited are:
- Mamta Ajay Jindal - Whole-Time Director
- Ishaan Jindal - Whole-Time Director
- Ajay Shrikrishan Jindal - Managing Director
- Shrikrishan Parameshwaridas Jindal - Whole-Time Director
- Krishnabai Shrikrishan Jindal - Whole-Time Director
- Aashna Ajay Jindal - Whole-Time Director
The primary industry of Jindal Drugs Private Limited is chemicals and materials. The company specifically operates in specialty chemicals. The company is currently active in this sector.
Jindal Drugs Private Limited can be reached at the registered office: 12A Bakhtawar 12Th Floor 229 Nariman Point, Mumbai, Maharashtra, India – 400021, or through the website jindaldrugs.com.
The authorised capital is ₹27.26 Cr, and the paid-up capital is ₹11.96 Cr.